title: Assessing the burden and management of chemotherapy induced emesis in the Asia/Pacific region.
authors.affiliation: Cancer Council Australia, Sydney, NSW, Australia, ian.olver@cancer.org.au.
authors.forename: Ian
authors.initials: I
authors.lastname: Olver
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001208:Asia; D017281:Cost of Illness; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy; D064729:Neurokinin-1 Receptor Antagonists / Q000627:therapeutic use*; D018040:Receptors, Neurokinin-1 / Q000187:drug effects; D058831:Serotonin 5-HT3 Receptor Antagonists / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D064729:Neurokinin-1 Receptor Antagonists; D018040:Receptors, Neurokinin-1; D058831:Serotonin 5-HT3 Receptor Antagonists
references.citation: Cancer. 2004 Dec 1;101(11):2701-8
references.pmid: 15517574
references.citation: Med J Aust. 2013 Nov 4;199(9):569-70
references.pmid: 24182206
references.citation: J Pain Symptom Manage. 2007 Aug;34(2):148-59
references.pmid: 17509816
references.citation: Support Care Cancer. 2014 Oct;22(10):2749-56
references.pmid: 24805911
references.citation: J Support Oncol. 2012 Jul-Aug;10(4):149-54
references.pmid: 22222249
references.citation: Eur J Pharmacol. 2014 Jan 5;722:197-202
references.pmid: 24157984
references.citation: Ann Oncol. 2012 Aug;23(8):1986-1992
references.pmid: 22396444
references.citation: Cancer. 2004 May 15;100(10):2261-8
references.pmid: 15139073
references.citation: J Pain Symptom Manage. 2014 May;47(5):839-848.e4
references.pmid: 24075401